TABLE OF CONTENTS |
December 2016 Volume 22, Issue 12 |
 |  |  |
 | Editorial News Correspondence News and Views Perspective Articles Letters Corrigenda Errata
| |
 |
|
 |
 |
Advertisement |
 |
Nature Outlook: Parkinson's disease It is 200 years since Parkinson's disease was first described. This Outlook charts the progress of research in an engaging timeline and shows how our understanding of Parkinson's motor and non-motor symptoms has evolved. It also reveals the exciting new applications of smartphones in monitoring the disease. Access the Outlook free online |  | | |
 |
|
Advertisement |
 |
Nature Outlook: Kidney Cancer
Kidney cancer has long flown under the radar despite being one of the top-ten cancer killers worldwide. It remains hard to detect, difficult to treat and poorly understood. But that is starting to change as researchers dig into the mysteries surrounding the disease.
Access the Outlook free online for six months
Produced with support from: Eisai Inc. | | | |
 |
|
Advertisement |
 |
Nature Insight: Neurodegenerative Diseases This Insight explores brain ageing and possible rejuvenation and updates our understanding of Alzheimer’s disease, amyotrophic lateral sclerosis and Parkinson’s disease. It also discusses how knowledge from prion disease may apply to more common neurodegenerative disorders and provides a structural perspective on the properties of amyloids. Access the Insight free online Produced with support from: Eli Lilly and Company | | | |
 |
|
Editorial | Top |
 |
 |
 |
Crystallizing sugar science p1369 doi:10.1038/nm.4250 Recent ballot initiatives instituting a tax on sugary drinks in the US, alongside related efforts by other countries and support from the World Health Organization, bring to the forefront the need for greater scientific insight into how sugars affect metabolic health.
|
 |
News | Top |
 |
 |
 |
Sex on the brain: Unraveling the differences between women and men in neurodegenerative disease pp1370 - 1372 Mike May doi:10.1038/nm1216-1370
|
 |
 |
 |
The Yearbook p1373 Shraddha Chakradhar doi:10.1038/nm1216-1373 From tech billionaires turned medical philanthropists to a crusader for improved drug safety, our list of newsmakers this year includes a number of hyper-ambitious individuals.
|
 |
 |
 |
Notable advances 2016 pp1374 - 1376 Hannah Stower, Tanya Bondar, Alison Farrell, Michael Basson, Randy Levinson et al. doi:10.1038/nm1216-1374 This past year saw breakthroughs in areas ranging from gene editing to eye-tissue repair. Here are a few of the research papers that reported some of the exciting discoveries of 2016.
|
 |
 |
 |
Drugs that made headlines in 2016 pp1377 - 1379 Amanda B. Keener doi:10.1038/nm1216-1377 Gene therapies featured prominently among this year's newsworthy drugs, some of which have already received a green light from regulatory agencies for sale or are otherwise surging forward in trials. Other drugs ended the year with a much less rosy efficacy or safety profile.
|
 |
 |
 |
Timeline of events pp1380 - 1381 Shraddha Chakradhar doi:10.1038/nm1216-1380 From an alarming global health emergency to an increased focus on antibiotic resistance, 2016 was a year replete with attention on infectious disease. But the year also included events ranging from clinical trials gone horribly awry to calls for expanded access to marijuana for research.
|
 |
Correspondence | Top |
 |
 |
 |
Neutrophils are not required for resolution of acute gouty arthritis in mice pp1382 - 1384 Laurent L Reber, Nicolas Gaudenzio, Philipp Starkl and Stephen J Galli doi:10.1038/nm.4216
|
 |
 |
 |
Reply to "Neutrophils are not required for resolution of acute gouty arthritis in mice" pp1384 - 1386 Christiane Reinwald, Christine Schauer, Janka Zsofia Csepregi, Deborah Kienhofer, Daniela Weidner et al. doi:10.1038/nm.4217
|
 |
News and Views | Top |
 |
 |
 |
|
 |
Perspective | Top |
 |
 |
 |
Patient-derived induced pluripotent stem cells in cancer research and precision oncology pp1392 - 1401 Eirini P Papapetrou doi:10.1038/nm.4238 Cancer-derived induced pluripotent stem cells provide a new opportunity to model the effects of the cancer genome. In this Perspective, Eirini Papapetrou discusses the future applications of these cells for cancer modeling and therapeutic understanding.
|
 |
Advertisement |
 |
|
 |
|
Articles | Top |
 |
 |
 |
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses pp1402 - 1410 Kelly D Moynihan, Cary F Opel, Gregory L Szeto, Alice Tzeng, Eric F Zhu et al. doi:10.1038/nm.4200 An immunotherapy consisting of a tumor-antigen targeting antibody, PD-1 blocking antibody, extended half-life recombinant IL-2 and a lymph-node-targeted T cell vaccine mobilized innate and adaptive immunity and eradicated large established tumors in a variety of mouse models.
See also: News and Views by Palucka & Banchereau |
 |
 |
 |
IAP antagonists induce anti-tumor immunity in multiple myeloma pp1411 - 1420 Marta Chesi, Noweeda N Mirza, Victoria M Garbitt, Meaghen E Sharik, Amylou C Dueck et al. doi:10.1038/nm.4229 Blockade of cIAP1 and cIAP2 induces a tumor cell-autonomous type-I IFN response that activates myeloid cells and potentiates anti-tumor immunity in pre-clinical models and patients with multiple myeloma.
|
 |
 |
 |
Capturing the biology of disease severity in a PSC-based model of familial dysautonomia pp1421 - 1427 Nadja Zeltner, Faranak Fattahi, Nicole C Dubois, Nathalie Saurat, Fabien Lafaille et al. doi:10.1038/nm.4220 Using induced pluripotent stem cells from patients with familial dysautonomia, the authors show that in vitro models can recapitulate patient-specific differences in disease severity.
|
 |
 |
 |
Cardioprotection and lifespan extension by the natural polyamine spermidine pp1428 - 1438 Tobias Eisenberg, Mahmoud Abdellatif, Sabrina Schroeder, Uwe Primessnig, Slaven Stekovic et al. doi:10.1038/nm.4222 Spermidine, a naturally occurring polyamine, extends the lifespan of mice and is cardioprotective in both aged mice and hypertensive rats. In humans, high dietary spermidine intake is associated with reduced blood pressure and a lower incidence of cardiovascular disease.
See also: News and Views by de Cabo & Navas |
 |
 |
 |
Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies pp1439 - 1447 Surender Khurana, Sandra Fuentes, Elizabeth M Coyle, Supriya Ravichandran, Richard T Davey Jr et al. doi:10.1038/nm.4201 Surender Khurana and colleagues analyzed the antibody repertoire in healthy individuals after vaccination against Ebola virus using a VSV-Ebola vaccine and identify a strong contribution of IgM antibodies to the virus-neutralizing response.
|
 |
 |
 |
Zika viral dynamics and shedding in rhesus and cynomolgus macaques pp1448 - 1455 Christa E Osuna, So-Yon Lim, Claire Deleage, Bryan D Griffin, Derek Stein et al. doi:10.1038/nm.4206 Both rhesus and cynomolgus macaques are susceptible to subcutaneous infection with Zika virus; longitudinal studies of infected animals provide information about the temporal dynamics of Zika virus in distinct cells, tissues and body fluids, as well as the immune response to the virus.
|
 |
 |
 |
Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination pp1456 - 1464 Jiwon Lee, Daniel R Boutz, Veronika Chromikova, M Gordon Joyce, Christopher Vollmers et al. doi:10.1038/nm.4224 Antibodies that bind to both H1 and H3 influenza strains exist in the pre-vaccination serum repertoire of healthy adults; most vaccine-elicited clonotypes bind either H1 or H3 strains.
See also: Letter by Raymond et al. | News and Views by Webby |
 |
Advertisement |
 |
Poster on Molecular mechanisms of amyotrophic lateral sclerosis This poster from Nature Reviews Neuroscience provides an overview of the molecular and cellular mechanisms that have been proposed to contribute to the pathogenesis of amyotrophic lateral sclerosis, which is the most common form of motor neuron disease. Download free online Funded by a grant from MT Pharma America, Inc | | | |
 |
|
Letters | Top |
 |
 |
 |
Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain pp1465 - 1469 Donald D Raymond, Shaun M Stewart, Jiwon Lee, Jack Ferdman, Goran Bajic et al. doi:10.1038/nm.4223 Antibodies elicited by vaccination with influenza vaccine produced in eggs bind more strongly to the egg-adapted vaccine strain than to wild-type circulating strains.
See also: Article by Lee et al. | News and Views by Webby |
 |
 |
 |
Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis pp1470 - 1474 Tami D Lieberman, Douglas Wilson, Reshma Misra, Lealia L Xiong, Prashini Moodley et al. doi:10.1038/nm.4205 Genomic analysis of Mycobacterium tuberculosis in postmortem biopsies provides a window into intrahost diversification of a disseminated pathogen.
|
 |
 |
 |
Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling pp1475 - 1481 Abigail Jarret, Adelle P McFarland, Stacy M Horner, Alison Kell, Johannes Schwerk et al. doi:10.1038/nm.4211 Ram Savan and colleagues report that two miRNAs known to suppress type 3 interferon (IFN) signaling also downregulate type 1IFN signaling in hepatitis C virus (HCV)-infected hepatocytes. The findings provide insights into the mechanisms by which antiviral IFN signaling is inhibited in HCV infection.
|
 |
 |
 |
Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes pp1482 - 1487 Jenny Aurielle B Babon, Megan E DeNicola, David M Blodgett, Inne Crevecoeur, Thomas S Buttrick et al. doi:10.1038/nm.4203 Analysis of T cells isolated from patients with and without type 1 diabetes reveals reactivity to a range of native as well as post-translationally modified self-antigens only in individuals with T1D.
|
 |
 |
 |
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling pp1488 - 1495 Olga A Guryanova, Kaitlyn Shank, Barbara Spitzer, Luisa Luciani, Richard P Koche et al. doi:10.1038/nm.4210 AML cells carrying R882 mutations in DNMT3A fail to sense and repair DNA damage induced by standard-dose chemotherapy as a result of impaired chromatin remodeling
|
 |
 |
 |
Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism pp1496 - 1501 Akihiko S Kato, Kevin D Burris, Kevin M Gardinier, Douglas L Gernert, Warren J Porter et al. doi:10.1038/nm.4221 Selective pharmacological blockade of forebrain excitatory AMPA receptors that express the TARP γ-8 subunit enables antiepileptic therapy in rodent models of epilepsy without inducing motor impairments associated with currently used antiepileptic drugs.
|
 |
Corrigenda | Top |
 |
 |
 |
Corrigendum: Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming p1502 Mark J Kwakkenbos, Sean A Diehl, Etsuko Yasuda, Arjen Q Bakker, Caroline M M van Geelen et al. doi:10.1038/nm1216-1502a
|
 |
 |
 |
Corrigendum: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET p1502 Hector Peinado, Masa Alecˇkovic, Simon Lavotshkin, Irina Matei, Bruno Costa-Silva et al. doi:10.1038/nm1216-1502b
|
 |
Errata | Top |
 |
 |
 |
Erratum: Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation p1502 Huanjiao Jenny Zhou, Lingfeng Qin, Haifeng Zhang, Wenwen Tang, Weidong Ji et al. doi:10.1038/nm1216-1502c
|
 |
 |
 |
Erratum: Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection p1502 Joseph P Zackular, Jessica L Moore, Ashley T Jordan, Lillian J Juttukonda, Michael J Noto et al. doi:10.1038/nm1216-1502d
|
 |
Top |
 |
 |
Advertisement |
 |
|
 |
|
 |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  |
|
 |
No comments:
Post a Comment